Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNF7P1 (ring finger protein 7 pseudogene 1) is a human pseudogene homologous to the functional RNF7 (ring finger protein 7) gene, which encodes a component of the ubiquitin-proteasome system essential for protein degradation and cell cycle regulation[1][3][5]. As a pseudogene, RNF7P1 is classified as a non-protein-coding genomic locus: it does not produce a functional protein product, and there is no evidence it serves as a direct therapeutic target or biomarker. While some human pseudogenes have regulatory RNA functions, there is no documented functional role or disease association for RNF7P1 specifically. It is important not to confuse RNF7P1 with the functional RNF7, which is involved in ubiquitin ligase complexes and implicated in various cancers and cell regulatory pathways[3][5]. Because RNF7P1 is a pseudogene and does not encode a functional protein or receptor, it is not considered a drug target, nor is it a subject of clinical intervention or mechanistic pharmacology[1][4].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 7 pseudogene 1 (RNF7P1).